Motor Control During Rapid Eye Movement (REM) Sleep Behaviour Disorder

Not Applicable

Terminated

• Conditions: Parkinson Disease
• Interventions: Other: Synchronised video-polysomnography

• Registration Number: NCT01886131
• Lead Sponsor: University Hospital, Toulouse

Brief Summary

To compare the electrical activity of SubThalamic Nuclei (STN), by mean of local field potentials recordings, during the phasic behaviours of RBD with the electrical activity recorded at this level during the execution of voluntary movements during the "off" and the "on" phases in patients with RBD secondary to PD.

Detailed Description

Patient with severe Parkinson's disease (PD) with motor fluctuations are akinetic and bradykinetic during the "off" phases. Their motor status dramatically improves during "on" phases, due to the effect of dopaminergic agents.

In the off phases, the plasmatic levels of dopaminergic drugs are the lowest. The plasmatic levels of dopaminergic drugs are also very low during nocturnal sleep.

Nevertheless, PD patients may show vigorous and rapid movements during REM Behaviour Disorder (RBD). Thirty-three to 46% of the patients with PD have RBD.

Akinesia and bradykinesia are the consequence of a hyperactivity of the SubThalamic Nuclei (STN). The electrophysiological correlate of this hyperactivity causing akinesia and bradykinesia is represented by STN beta activity, recorded by local field potentials.

STN beta activity is not present during the execution of a voluntary movement at an "on" phase. Levodopa therapy, which can revert akinesia and bradykinesia, also suppress STN beta activity in PD patients The STN is the surgical target for Deep Brain Stimulation (DBS) of the basal ganglia to improve the motor symptoms of PD.

The STN has bilateral connections with the laterodorsal nucleus/pedunculopontine tegmentum (LDT/PPN), a key structure for REM sleep regulation.

The investigators hypothesize that during the execution of the phasic motor behaviours of RBD the pattern of discharge of STN differs from the one observed during voluntary movements in the "off" phase, in PD patients. In other terms, we expect the STN beta activity to disappear during the execution of phasic motor behaviors of RBD.

Study Timeline

• Study Start: 2013-06
• Study First Submitted: 2013-06-20
• Study First Submitted QC: 2013-06-24
• Study First Posted: 2013-06-25
• Primary Completion: 2014-06
• Study Completion: 2014-07
• Status Verified: 2017-02
• Last Update Submitted: 2017-02-21
• Last Update Posted: 2017-02-23

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 3

Inclusion Criteria

• Men and women, 35 to 70 years old, with idiopathic PD (UKPDSBB criteria) with motor fluctuations
• having RBD according to the International Classification of Sleep Disorders, 2nd edition (ICSD-2) criteria
• Eligible to neurosurgical treatment of PD by implantation of intracranial electrodes for the DBS of STN
• Giving a written informed consent
• Affiliated to the French social security program

Exclusion Criteria

• Atypical or secondary parkinsonian syndrome
• Cognitive impairment which may compromise the understanding and patient's participation to the protocol (Mattis dementia rating scale score ≥ 136)
• Patient under guardianship, trusteeship or judicial protection
• Pregnancy or breastfeeding
• Patient participating to another clinical research study in the same period

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Synchronised video-polysomnography	Synchronised video-polysomnography	-

Primary Outcome Measures

Name	Time	Method
STN 8-30 Hz mean power	Outcome measure is assessed during the 2 nights and the two days following the implantation of the electrode in the STN.	Difference of the mean power of the 8-30 Hz frequency band at the NST during the phasic movements of TCSP and during the execution voluntary movements in the "off" phase.

Secondary Outcome Measures

Name	Time	Method
Difference of the mean power of the 8-30 Hz and 60-90 Hz frequency bands at the NST during the phasic movements of TCSP and during the execution voluntary movements in the "on" phase.	Outcome measures are assessed at days 2 and 3 and nights 1 and 2.
Frequency spectrum at the NST during non REM sleep (N1, N2 and N3 stages), REM sleep (R) and nocturnal wake.	Outcome measures are assessed at days 2 and 3 and nights 1 and 2
Frequency spectrum at NST REM sleep without atonia and REM sleep with atonia.	Outcome measures are assessed at days 2 and 3 and nights 1 and 2.
Difference of the mean power of the 8-13 Hz, 14-30 Hz and 60-90 Hz frequency bands at the NST during the phasic movements of TCSP and during the execution voluntary movements in the "off" phase.	Outcome measures are assessed at days 2 and 3 and nights 1 and 2.

Trial Locations

Locations (2)

University Hospital of Rangueil; 🇫🇷 Toulouse, Midi-Pyrénées, France

University Hospital of Purpan; 🇫🇷 Toulouse, Midi-Pyrénées, France